Literature DB >> 18838437

Validation of modelling the radiation exposure due to solar particle events at aircraft altitudes.

P Beck1, D T Bartlett, P Bilski, C Dyer, E Flückiger, N Fuller, P Lantos, G Reitz, W Rühm, F Spurny, G Taylor, F Trompier, F Wissmann.   

Abstract

Dose assessment procedures for cosmic radiation exposure of aircraft crew have been introduced in most European countries in accordance with the corresponding European directive and national regulations. However, the radiation exposure due to solar particle events is still a matter of scientific research. Here we describe the European research project CONRAD, WP6, Subgroup-B, about the current status of available solar storm measurements and existing models for dose estimation at flight altitudes during solar particle events leading to ground level enhancement (GLE). Three models for the numerical dose estimation during GLEs are discussed. Some of the models agree with limited experimental data reasonably well. Analysis of GLEs during geomagnetically disturbed conditions is still complex and time consuming. Currently available solar particle event models can disagree with each other by an order of magnitude. Further research and verification by on-board measurements is still needed.

Entities:  

Mesh:

Year:  2008        PMID: 18838437     DOI: 10.1093/rpd/ncn238

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  2 in total

1.  Measurements of secondary neutrons from cosmic radiation with a Bonner sphere spectrometer at 79 degrees N.

Authors:  Werner Rühm; V Mares; C Pioch; E Weitzenegger; R Vockenroth; H G Paretzke
Journal:  Radiat Environ Biophys       Date:  2009-02-27       Impact factor: 1.925

Review 2.  All for one, though not one for all: team players in normal tissue radiobiology.

Authors:  Marjan Boerma; Catherine M Davis; Isabel L Jackson; Dörthe Schaue; Jacqueline P Williams
Journal:  Int J Radiat Biol       Date:  2021-07-01       Impact factor: 2.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.